DI VICO, FRANCESCA
 Distribuzione geografica
Continente #
AS - Asia 963
NA - Nord America 511
EU - Europa 432
SA - Sud America 87
AF - Africa 28
Totale 2.021
Nazione #
US - Stati Uniti d'America 488
SG - Singapore 363
RU - Federazione Russa 228
CN - Cina 222
VN - Vietnam 191
BR - Brasile 68
IT - Italia 60
HK - Hong Kong 42
DE - Germania 41
BD - Bangladesh 35
FR - Francia 33
IN - India 31
JP - Giappone 27
KR - Corea 22
GB - Regno Unito 14
CA - Canada 11
CI - Costa d'Avorio 11
NL - Olanda 11
FI - Finlandia 8
AR - Argentina 7
MX - Messico 7
PH - Filippine 7
PL - Polonia 7
EG - Egitto 6
AT - Austria 5
IQ - Iraq 5
PT - Portogallo 5
UA - Ucraina 5
CL - Cile 3
ES - Italia 3
PS - Palestinian Territory 3
SE - Svezia 3
ZA - Sudafrica 3
CO - Colombia 2
EC - Ecuador 2
HR - Croazia 2
ID - Indonesia 2
MA - Marocco 2
PK - Pakistan 2
PY - Paraguay 2
SA - Arabia Saudita 2
TH - Thailandia 2
VE - Venezuela 2
AL - Albania 1
AM - Armenia 1
BO - Bolivia 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
IE - Irlanda 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
LT - Lituania 1
LV - Lettonia 1
MN - Mongolia 1
OM - Oman 1
SC - Seychelles 1
SI - Slovenia 1
SO - Somalia 1
TR - Turchia 1
ZW - Zimbabwe 1
Totale 2.021
Città #
Singapore 179
San Jose 174
Hefei 100
Ashburn 53
Moscow 53
Ho Chi Minh City 50
Beijing 44
Hanoi 44
Hong Kong 41
Santa Clara 39
Tokyo 22
Seoul 18
Council Bluffs 17
Lauterbourg 17
Kochi 15
Los Angeles 13
The Dalles 10
Redondo Beach 9
Buffalo 8
New York 8
Haiphong 7
Amsterdam 6
Da Nang 6
Dallas 6
Mexico City 6
Milan 6
São Paulo 6
Atlanta 5
Cairo 5
Frankfurt am Main 5
Lappeenranta 5
Naples 5
Nuremberg 5
Schoenwalde 5
Baghdad 4
Biên Hòa 4
Brooklyn 4
Chennai 4
Coimbra 4
Denver 4
London 4
New Delhi 4
Orem 4
Rome 4
Vienna 4
Warsaw 4
Bengaluru 3
Boston 3
Calgary 3
Can Tho 3
Catania 3
Helsinki 3
Kyiv 3
Lawrence 3
Millbury 3
Phoenix 3
Poplar 3
Rio de Janeiro 3
Stockholm 3
Wroclaw 3
Arezzo 2
Avaré 2
Bến Tre 2
Cavallino 2
Chicago 2
Collegno 2
Curitiba 2
Falkenstein 2
Freiburg im Breisgau 2
Gravataí 2
Hòa Bình 2
Hải Dương 2
Johannesburg 2
Kronberg 2
Long Xuyen 2
Miami 2
Montreal 2
Munich 2
Nha Trang 2
Ninh Bình 2
Nova Friburgo 2
Palermo 2
Paris 2
Pavia 2
Quito 2
Quận Bình Thạnh 2
Roubaix 2
Salvador 2
San Francisco 2
Santa Luzia 2
Secaucus 2
The Bronx 2
Thái Bình 2
Abidjan 1
Acevedo 1
Addis Ababa 1
Altinordu 1
Alto Paraíso de Goiás 1
Ananindeua 1
Andria 1
Totale 1.155
Nome #
A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years 154
Effectiveness and Safety of Upadacitinib for Adolescents with Atopic Dermatitis in a Real-World Setting 143
Airborne and systemic allergic contact dermatitis due to corticosteroids 134
Reply to: Upadacitinib for the management of overlapping psoriasis and atopic dermatitis: a case series 133
Effectiveness of Janus Kinase Inhibitors for the Management of Atopic Dermatitis and Concomitant Occupational Allergic Contact Dermatitis: A Real-Life Study 133
Psychological teleconsultations in patients suffering from chronic skin diseases during the COVID-19 era: a service to improve patients’ quality of life 129
Oral isotretinoin for acne: a complete overview 127
The hidden sentinel of the skin: An overview on the role of interleukin-13 in atopic dermatitis 122
Long-term efficacy of telemedicine for patients with locally advanced basal cell carcinoma during COVID-19 pandemic 107
The impact of COVID-19 pandemic on nonmelanoma skin cancers: report of a Southern Italy referral centre 105
Letter to the editor submitted in response to ‘Incidence and prognosis of COVID-19 in patients with atopic diseases on dupilumab: a multicentre retrospective cohort study’ 104
Small vessel vasculitis related to varicella-zoster virus after Pfizer-BioNTech COVID-19 vaccine 102
Comment on ‘Efficacy and tolerance of dupilumab in patients with moderate-to-severe atopic dermatitis and obesity’ by Dupuis et al 95
Effectiveness, Safety, and Long-Term Continuation Rate Analysis of Dupilumab Treatment in Adolescents with Atopic Dermatitis: A Single-Center Real-Life Retrospective Study 91
Strategies to Improve Outcomes of Bullous Pemphigoid: A Comprehensive Review of Clinical Presentations, Diagnosis, and Patients' Assessment 88
Resistance to hedgehog inhibitors in basal cell carcinoma: strategies to adopt 85
Allergic Contact Dermatitis From a Polyester Trouser Mimicking Atopic Dermatitis 64
Therapeutic outcomes across Janus kinase inhibitors in prurigo nodularis 33
Imatinib-induced lichen planopilaris: a combined therapeutic approach 27
Effectiveness of Tralokinumab Across Atopic Dermatitis Phenotypes 25
Baricitinib for adult atopic dermatitis: real-world effectiveness, safety, and response predictors 20
Letter: Atopic Dermatitis, 2-HEMA Allergic Contact Dermatitis, and Chemical Leukoderma: Which Relationship? 19
Persistence of biologics and Janus kinase inhibitors in atopic dermatitis: preliminary 24-month analysis 3
Open-label, uncontrolled clinical investigation of the performance and safety of a foam containing a hyaluronic acid-derived biopolymer and humectants for management of dermatitis in adults 2
Treatment Trajectories and Dose Optimization of Abrocitinib in Moderate-to-Severe Atopic Dermatitis: A Real-World Landmark Analysis 1
Effectiveness of Baricitinib in Treating Atopic Dermatitis in Difficult-to-treat Areas: A Retrospective Real-world Study 1
Real-Life Effectiveness and Safety of Lebrikizumab in Elderly Patients with Atopic Dermatitis: A Multicenter Study 1
Longitudinal Response Trajectories with Dupilumab or Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A Multicentre Real-World Study: IL-AD (Italian Landscape Atopic Dermatitis) 1
Totale 2.049
Categoria #
all - tutte 6.811
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.811


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202210 0 0 0 0 0 0 0 0 0 1 3 6
2022/202336 3 0 0 1 0 1 1 2 1 7 11 9
2023/202487 0 11 23 7 9 2 2 14 3 0 9 7
2024/2025545 15 20 5 15 18 38 35 47 33 56 196 67
2025/20261.335 131 123 137 101 195 25 153 106 210 71 21 62
2026/202736 36 0 0 0 0 0 0 0 0 0 0 0
Totale 2.049